Previous Close | $17.38 |
Intrinsic Value | $2.58 |
Upside potential | -85% |
Data is not available at this time.
Spok Holdings, Inc. operates in the healthcare communications sector, providing critical connectivity solutions for hospitals, clinics, and emergency services. The company’s core revenue model is driven by software subscriptions, support services, and hardware sales, primarily through its Spok Care Connect® and Spok Mobile® platforms. These solutions enable secure messaging, clinical alerting, and workflow optimization, positioning Spok as a trusted partner in an industry where real-time communication is vital for patient care and operational efficiency. Spok competes in a niche but growing market, leveraging its deep domain expertise and long-standing relationships with healthcare providers. Unlike generic communication tools, its platforms are tailored to meet stringent compliance and interoperability requirements, giving it a defensible position against broader tech entrants. The company’s focus on mission-critical use cases, such as emergency response and clinician coordination, underscores its differentiation in a fragmented competitive landscape.
Spok reported revenue of $137.7 million for FY 2024, with net income of $14.97 million, reflecting a net margin of approximately 10.9%. Operating cash flow stood at $28.9 million, demonstrating solid cash conversion. Capital expenditures of $3.2 million suggest moderate reinvestment needs, aligning with the company’s asset-light software-centric model. The diluted EPS of $0.73 indicates steady earnings power relative to its share count.
The company’s ability to generate $28.9 million in operating cash flow against $14.97 million in net income highlights efficient working capital management. With minimal debt ($8.8 million) and $29.1 million in cash, Spok maintains a conservative capital structure. Its capital-light model allows for high free cash flow generation, supporting both dividends and potential strategic investments.
Spok’s balance sheet remains robust, with $29.1 million in cash and equivalents against total debt of $8.8 million, yielding a net cash position. The low leverage ratio underscores financial stability, while the absence of significant liabilities suggests ample flexibility for growth or shareholder returns. The company’s financial health is further reinforced by consistent positive cash flows.
Spok’s growth is tempered by its mature market, but recurring software revenue provides stability. The $1.25 annual dividend per share, supported by strong free cash flow, signals a commitment to returning capital to shareholders. While top-line expansion may be modest, margin resilience and cash flow predictability underpin its dividend sustainability.
With a market cap derived from 20.2 million shares outstanding, Spok’s valuation likely reflects its steady but slow-growth profile. Investors may prize its dividend yield and cash flow stability over aggressive expansion, aligning with a value-oriented investment thesis. The stock’s performance will hinge on execution in healthcare IT and retention of its niche positioning.
Spok’s deep integration into healthcare workflows and compliance expertise provide durable competitive advantages. The outlook remains stable, with opportunities in cross-selling advanced features and expanding internationally. Risks include competition from unified communication platforms, but Spok’s focus on critical-use cases and regulatory adherence should sustain its relevance.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |